These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2943770)

  • 101. Life events and the dexamethasone suppression test in affective illness.
    Mendlewicz J; Charon F; Linkowski P
    J Affect Disord; 1986; 10(3):203-6. PubMed ID: 2943773
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls.
    Hunt GE; Johnson GF; Caterson ID
    J Affect Disord; 1989; 17(1):21-32. PubMed ID: 2525575
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [3H]yohimbine binding to platelet alpha 2-adrenoceptors in depression.
    Katona CL; Theodorou AE; Davies SL; Hale AS; Kerry SM; Horton RW; Kelly JS; Paykel ES
    J Affect Disord; 1989; 17(3):219-28. PubMed ID: 2551946
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Spontaneous afternoon plasma cortisol in depression.
    Christensen P; Gram LF; Kragh-Søensen P; Christensen L; Kristensen CB; Pedersen OL; Thomsen HY
    J Affect Disord; 1985; 8(3):271-8. PubMed ID: 3160738
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Effects of age on spontaneous cortisolaemia of normal volunteers and depressed patients.
    Maes M; Calabrese J; Lee M; Meltzer HY
    Psychoneuroendocrinology; 1994; 19(1):79-84. PubMed ID: 9210214
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Tritiated imipramine binding sites in affective disorders and schizophrenia. Influence of circannual variation.
    Desmedt DH; Egrise D; Mendlewicz J
    J Affect Disord; 1987; 12(3):193-8. PubMed ID: 2440932
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The unipolar-bipolar depressive dichotomy and the relationship between afternoon prolactin and cortisol levels.
    Joyce PR; Sellman JD; Donald RA; Livesey JH; Elder PA
    J Affect Disord; 1988; 14(2):189-93. PubMed ID: 2966833
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Seasonal variation of cortisol plasma levels in depressives.
    van Bemmel AL; van Diest R; Smeets EH; van Dongen PH; Hilgersom AJ
    J Affect Disord; 1988; 15(2):191-3. PubMed ID: 2975691
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Diagnostic performance of the thirty-four hour dexamethasone suppression test.
    Ansseau M; Doumont A; Cerfontaine JL; Sulon J; Demey-Ponsart E; Geenen V; Legros JJ
    Psychoneuroendocrinology; 1985; 10(2):215-9. PubMed ID: 4034851
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Results of dexamethasone suppression test in early Alzheimer dementia.
    De Leo D; Schifano F; Magni G
    Eur Arch Psychiatry Neurol Sci; 1988; 238(1):19-21. PubMed ID: 3215214
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatients.
    Peselow ED; Goldring N; Stanley M; Barouche F; Fieve RR
    Int Clin Psychopharmacol; 1986 Jan; 1(1):17-23. PubMed ID: 3549869
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
    Monreal JA; Duval F; Mokrani MC; Fattah S; Palao D
    J Psychiatr Res; 2019 May; 112():18-22. PubMed ID: 30836201
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding.
    Kathol RG
    J Affect Disord; 1985; 8(2):137-45. PubMed ID: 3157722
    [TBL] [Abstract][Full Text] [Related]  

  • 114. The cortisol suppressing effect of dexamethasone and oxazepam in depressed patients; significance of spontaneous levels and interindividual distribution.
    Christensen P; Gram LF; Lolk A; Kragh-Sørensen P
    J Affect Disord; 1987; 13(3):273-8. PubMed ID: 2960720
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Dexamethasone suppression test as a predictor of drug treatment response.
    Arató M; Rihmer Z; Szádóczky E; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):649-52. PubMed ID: 6152343
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Plasma HVA levels in depressed patients and controls.
    Roy A
    J Affect Disord; 1988; 14(3):293-6. PubMed ID: 2968391
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Prediction of efficacy of antidepressant by 1-week test therapy in depression.
    Nagayama H; Nagano K; Ikezaki A; Tashiro T
    J Affect Disord; 1991 Dec; 23(4):213-6. PubMed ID: 1791266
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Inositol treatment has no effect on the dexamethasone suppression test.
    Levine J; Leventhal U; Lerner V; Belmaker RH
    World J Biol Psychiatry; 2001 Oct; 2(4):190-2. PubMed ID: 12587148
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients.
    Møller SE; Kirk L; Honoré P
    J Affect Disord; 1980 Mar; 2(1):47-59. PubMed ID: 6448880
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
    Möller HJ; Kissling W; Bottermann P
    Eur Arch Psychiatry Neurol Sci; 1986; 235(5):263-8. PubMed ID: 3732336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.